HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pilot study of pyridostigmine in constipated patients with autonomic neuropathy.

AbstractBACKGROUND:
The effects of cholinesterase inhibitors, which increase colonic motility in health, on chronic constipation are unknown. Our aims were to evaluate the efficacy of cholinesterase inhibitors for dysautonomia and chronic constipation and to assess whether acute effects could predict the long term response.
METHODS:
In this single-blind study, 10 patients with autonomic neuropathy and constipation were treated with placebo (2 weeks), followed by an escalating dose of pyridostigmine to the maximum tolerated dose (i.e., 180-540 mg daily) for 6 weeks. Symptoms and gastrointestinal transit were assessed at 2 and 8 weeks. The acute effects of neostigmine on colonic transit and motility were also assessed.
RESULTS:
At baseline, 4, 6, and 3 patients had delayed gastric, small intestinal, and colonic transit respectively. Pyridostigmine was well tolerated in most patients, improved symptoms in 4 patients, and accelerated the geometric center for colonic transit at 24 h by > or =0.7 unit in 3 patients. The effects of i.v. neostigmine on colonic transit and compliance predicted (P < 0.05) the effects of pyridostigmine on colonic transit.
CONCLUSIONS:
Pyridostigmine improves colonic transit and symptoms in some patients with autonomic neuropathy and constipation. The motor response to neostigmine predicted the response to oral pyridostigmine.
AuthorsAdil E Bharucha, Phillip A Low, Michael Camilleri, Duane Burton, Tonette L Gehrking, Alan R Zinsmeister
JournalClinical autonomic research : official journal of the Clinical Autonomic Research Society (Clin Auton Res) Vol. 18 Issue 4 Pg. 194-202 (Aug 2008) ISSN: 0959-9851 [Print] Germany
PMID18622640 (Publication Type: Controlled Clinical Trial, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cholinesterase Inhibitors
  • Neostigmine
  • Pyridostigmine Bromide
Topics
  • Adolescent
  • Adult
  • Aged
  • Autonomic Nervous System (drug effects)
  • Autonomic Nervous System Diseases (complications, drug therapy, physiopathology)
  • Cholinesterase Inhibitors (administration & dosage, therapeutic use)
  • Constipation (drug therapy, etiology, physiopathology)
  • Female
  • Gastrointestinal Transit (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Neostigmine (administration & dosage, therapeutic use)
  • Pilot Projects
  • Pyridostigmine Bromide (administration & dosage, adverse effects, therapeutic use)
  • Single-Blind Method

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: